Antonio Parente
Direttore/Membro del Consiglio presso Archivel Farma SL
Provenienza dei contatti di primo grado di Antonio Parente
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
l'Associació Catalana d'Empreses de Biotecnologia
l'Associació Catalana d'Empreses de Biotecnologia Miscellaneous Commercial ServicesCommercial Services l'Associació Catalana d'Empreses de Biotecnologia is business association operating company. It is engaged in promoting health and life sciences activities for biotechnology organizations, business leaders, senior executives, entrepreneurs, investors and journalists. The company was founded in 2006 and is headquartered in Barcelona, Spain.
7
| Private Company | Miscellaneous Commercial Services | 7 |
Archivel Farma SL
Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain.
6
| Private Company | Miscellaneous Commercial Services | 6 |
HAWK Biosystems
HAWK Biosystems Packaged SoftwareTechnology Services Fastbase Solutions SL operates an online cancer diagnostic software platform. The company is based in Derio, Spain. Fernando Aguirre has been the CEO of the Spanish company since 2018.
4
| Holding Company | Packaged Software | 4 |
Kintsugi Therapeutics
Kintsugi Therapeutics Pharmaceuticals: MajorHealth Technology Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Antalgenics SL
Antalgenics SL BiotechnologyHealth Technology Antalgenics SL is a Spanish biotechnological company that specializes in discovering and developing new bioactive molecules for biomedical and dermocosmetic applications. The company is based in Alicante, Spain. The company offers customized R & D services to design and develop projects according to the client's needs. The company's focus is on developing novel therapeutic leads, primarily for the treatment of psoriatic pruritus and psoriatic comorbidities. Antalgenics was founded in 2015, and the CEO is Philipp Tsolakis.
3
| Holding Company | Biotechnology | 3 |
Prospera Biotech SL
Prospera Biotech SL Household/Personal CareConsumer Non-Durables Prospera Biotech SL is a Spanish company that develops innovative solutions for sensitive skin caused by medical treatments and environmental agents. The company is based in Elche, Spain and was founded in 2019. The company's own formulations are free of aggressive agents and suitable for all types of skin. The company specializes in developing cosmetic formulations with innovative neurocosmetics for skin care in sensitive skin with a tendency to atopia, sensitive skins of people who have received chemotherapy and/or radiotherapy, sensitive skins in the intimate parts of the body, and excessive sweating. The CEO is Marta García.
3
| Holding Company | Household/Personal Care | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Antonio Parente tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
CHEVRON CORPORATION | Integrated Oil | Private Equity Investor | |
TIGENIX NV | Medical Specialties | Director/Board Member | |
Grupo Uvesco SL
Grupo Uvesco SL Food RetailRetail Trade Grupo Uvesco SL owns and operates a chain of supermarkets. It consists of more than 130 establishments, which are engaged in the distribution of food and non-food products. The group has supermarkets in the Álava, Bizkaia, Cantabria, Guipuzkoa, and Navarra regions. Grupo Uvesco was founded in 1994 and is headquartered in Los Corrales de Buelna, Spain. | Food Retail | Director/Board Member | |
EUSKALTEL, S.A. | Specialty Telecommunications | Director/Board Member | |
Indiana University | College/University | Graduate Degree | |
University of Barcelona | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Navarra | College/University | Graduate Degree | |
London Business School | College/University | Masters Business Admin | |
Polytechnic University of Catalonia | College/University | Undergraduate Degree | |
Icahn School of Medicine at Mount Sinai | College/University | Corporate Officer/Principal | |
VOZTELECOM OIGAA360 S.A. | Packaged Software | Director/Board Member Director/Board Member | |
Inveready Asset Management SGEIC SA
Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready Asset Management SGEIC SA (Inveready) is a private equity and venture capital subsidiary of Inveready Capital Co. SL founded in 2008 by Joseph Maria Echarri Torres. The firm is headquartered in San Sebastian, Spain. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Agrasys SL
Agrasys SL BiotechnologyHealth Technology Agrasys SL develops and commercialize crops and cereals. It offers Tritordeum, a non genetic modification cereals and developed for human nutrition. The company was founded in 2005 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Almirall Ltd.
Almirall Ltd. Pharmaceuticals: OtherHealth Technology Almirall Ltd. is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain. In Almirall they research, develop, produce and market proprietary R&D medicines and those under licence with the aim of improving people's health and wellbeing. They devote big human and economic resources to constant research into new drugs and to obtaining effective and safe products against discomfort and disease. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Instituto de Consejeros-Administradores | Corporate Officer/Principal | ||
Ability Pharmaceuticals SL
Ability Pharmaceuticals SL BiotechnologyHealth Technology Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
Codeoscopic SA
Codeoscopic SA Information Technology ServicesTechnology Services Codeoscopic SA provides information technology services. The company was founded on April 3, 2009 and is headquartered in Madrid, Spain. | Information Technology Services | Director/Board Member | |
VCN Biosciences SL
VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | Miscellaneous Commercial Services | Director/Board Member | |
Gri-Cel SA
Gri-Cel SA Financial ConglomeratesFinance Part of Grifols SA, Gri-Cel SA provides investment services. The company is based in Barcelona, Spain. The CEO of the Spanish company is Dirk Büscher. | Financial Conglomerates | Chief Operating Officer | |
IFFE FUTURA, S.A. | Real Estate Investment Trusts | Director/Board Member | |
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Founder | |
Zera Intein Protein Solutions SL
Zera Intein Protein Solutions SL BiotechnologyHealth Technology Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Innoup Farma SL
Innoup Farma SL BiotechnologyHealth Technology InnoUp Farma SL develops nanotechnology-based solutions for the administration of oral drugs. It offers anti-cancer drugs with low oral bioavailability. The company was founded by Maite Agueros Bazo, Manuel Rodriguez Mariscal and Juan Manuel Irache Garreta and is headquartered in Noain, Spain. | Biotechnology | Director/Board Member | |
Aquilón Cyl SL
Aquilón Cyl SL Medical/Nursing ServicesHealth Services Aquilón Cyl SL develops vaccines and probiotics to combat swine diseases. It develops the findings and inventions of Spanish research, basically in the veterinary medicine field. The company was founded by Nistal Pedro Miguel Rubio in March, 2012 and is headquartered in Leon, Spain. | Medical/Nursing Services | Chairman | |
Avizorex Pharma SL
Avizorex Pharma SL Medical/Nursing ServicesHealth Services Avizorex Pharma SL develops drugs for the treatment of the dry eye disease. The company was founded by Carlos Belmonte and Sauri Patrick Tresserras in July, 2013 and is headquartered in Barcelona, Spain. | Medical/Nursing Services | Director/Board Member | |
Nekko Capital SGEIC SA
Nekko Capital SGEIC SA Investment ManagersFinance Nekko Capital SGEIC SA is an Independent Venture Capital firm founded in 2015 by Félix Arias Gabasa, Mercè Tell García and Santiago Pi Figueras Valls. Nekko Capital SGEIC SA is headquartered in Barcelona with additional offices in Madrid and London. | Investment Managers | Founder | |
PARLEM TELECOM COMPANYIA DE TELECOMUNICACIONS, S.A. | Wireless Telecommunications | Director/Board Member | |
Leukos Biotech SL
Leukos Biotech SL Pharmaceuticals: MajorHealth Technology Leukos Biotech SL develops of new treatments for acute myeloid leukaemia and other haematological malignancies. The company was founded by Ruth Munoz Risueño in 2015 and is headquartered in Barcelona, Spain. | Pharmaceuticals: Major | Chief Executive Officer | |
Dozen Investments PFP SL
Dozen Investments PFP SL Financial ConglomeratesFinance Dozen Investments PFP SL is an online platform that allows investors to invest in selected startups with high profitability potential. The company is based in Madrid, Spain. The platform offers the opportunity to invest in the big startup tomorrow from €1,000 through the equity crowdfunding process. The Spanish company was founded by Donada Ramon Saltor and Joaquim Lopez Caussa, with Donada Ramon Saltor serving as the CEO since incorporation. | Financial Conglomerates | Director/Board Member | |
GoodlifeMe AB
GoodlifeMe AB Packaged SoftwareTechnology Services GoodlifeMe AB engages in the development of health games. It designs SidekickHealth, which is a social health game designed to engage users through health improvement and team building. The firm provides platform and app featuring programs for diet, physical activity, and stress management. The company was founded by Saemundur Jon Oddsson and Tryggvi Thorgeirsson and is headquartered in Gothenburg, Sweden. | Packaged Software | Director/Board Member | |
AptaTargets SL
AptaTargets SL Pharmaceuticals: MajorHealth Technology AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then. | Pharmaceuticals: Major | Director/Board Member | |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
Asociacion De Empresas Biotecnologicas
Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Biotechnology | Director/Board Member | |
Asabys Partners SGEIC SA
Asabys Partners SGEIC SA Investment ManagersFinance Asabys Partners SGEIC SA (Asabys Partners) is an independent venture capital firm founded in 2019 by Clara Campàs-Moya and Josep Lluís Sanfeliu Benet. The firm is headquartered in Barcelona, Spain. | Investment Managers | Founder | |
AmacaThera, Inc.
AmacaThera, Inc. Medical SpecialtiesHealth Technology AmacaThera, Inc. is biotechnology company, which engages in the development and commercialization of injectable hydrogel platform technology. Its platform addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. The company was founded by Molly S. Soichet and Mike Cooke and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member | |
Ona Therapeutics SL
Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
EDESA BIOTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
Oxolife SL
Oxolife SL BiotechnologyHealth Technology Oxolife SL operates as an biotech company focused on treating female infertility. The company was founded by Agn?s Arbat and Ignasi Canals in 2013 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Origo Biopharma SL
Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | Biotechnology | Chairman | |
Connecta Therapeutics SL
Connecta Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Connecta Therapeutics SL is an innovation-oriented, R&D-intensive organization committed to developing innovative treatments for patients. Connecta Therapeutics is based in Barcelona, ES. The Spanish company strongly believes in improving the lives of patients and their families and understands the importance of teamwork and collaboration to achieve their goals. The company was founded in 2019 by Josep Prous, David Prous, and Jordi Fàbrega. Jordi Fàbrega has been the CEO since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
ESADE Business School | College/University | Graduate Degree | |
S.G.E.C.R SA
S.G.E.C.R SA Investment ManagersFinance Part of Arcano Asesores Financieros SL, S.G.E.C.R SA is a Spanish company that provides financial advisory services. The company is based in Madrid, Spain. The company was founded by Fernando Javier Ortiz Vaamonde. The CEO is Josep María Echarri Torres. | Investment Managers | Chief Executive Officer | |
Grupo Financiero Inveready | Founder | ||
Immuni Therapeutics SL
Immuni Therapeutics SL BiotechnologyHealth Technology Immuni Therapeutics SL is a Spanish company that develops vaccines against COVID-19 and other viruses. The private company is based in Badalona, Spain. Immuni Therapeutics is promoted by Archivel Farma, the owner of the Ruti vaccine, which has yielded the rights for its development and commercialization to the new company. The Ruti vaccine is unique as it is based on the potentiation of the "trained innate immunity" in the patient, making it compatible with other vaccines and better adapted to the possible mutations of the virus or the arrival of new ones. Luis Antonio Ruiz-Avila has been the CEO of the company since 2020. | Biotechnology | Chief Executive Officer | |
Easo Ventures
Easo Ventures Investment ManagersFinance Easo Ventures is a venture capital arm of Stellum Gestora De Activos SGEIC SA founded in 2017. The firm is headquartered in Gipuzkoa, Basque Country. | Investment Managers | Private Equity Investor | |
AB-BIOTICS, S.A. | Pharmaceuticals: Other | Director/Board Member |
Statistiche
Distribuzione geografica
Spagna | 42 |
Stati Uniti | 4 |
Regno Unito | 3 |
Canada | 3 |
Belgio | 2 |
Settori
Health Technology | 19 |
Finance | 10 |
Consumer Services | 8 |
Commercial Services | 6 |
Technology Services | 4 |
Posizioni
Director/Board Member | 65 |
Chief Executive Officer | 13 |
Founder | 13 |
Undergraduate Degree | 11 |
Private Equity Investor | 7 |
Contatti più connessi
- Borsa valori
- Insiders
- Antonio Parente
- Connessioni Società